Skip to main content

Table 3 Medication Possession Rates (MPR) and Clinical Characteristics

From: Persistence and compliance to antidepressant treatment in patients with depression: A chart review

  MPR (mean ± SD)
Any antidepressant (n = 367) 0.77 ± 0.28
Initial antidepressant 0.71 ± 0.31
   Sulpiride (n = 148) 0.72 ± 0.28
   Paroxetine (n = 114) 0.70 ± 0.35
   Fluvoxamine(n = 34) 0.64 ± 0.30
   Sertraline(n = 33) 0.77 ± 0.28
   Milnacipran(n = 31) 0.78 ± 0.30
   Amoxapine (n = 5) 0.64 ± 0.27
   Trazodone (n = 2) 0.68 ± 0.64
  MPR of any antidepressant
Sex a  
   Female (n = 197) 0.73 ± 0.29
   Male (n = 170) 0.81 ± 0.26
Age group b  
   Before age 40 (n = 241) 0.76 ± 0.28
   40–59 (n = 95) 0.76 ± 0.25
   60 or older(n = 31) 0.87 ± 0.29
Anxiolytics use  
   No (n = 245) 0.77 ± 0.29
   Yes (n = 122) 0.77 ± 0.25
Hypnotics use  
   No (n = 191) 0.78 ± 0.29
   Yes (n = 176) 0.76 ± 0.27
  1. aUnivariate general linear model found that gender had significant effects on the MPR (F(1,343) = 4.43; Corrected Model: F(23,343) = 1.78, p = 0.016, R2 = 0.11).
  2. b Univariate general linear model found that age group had significant effects on the MPR (F(2,343) = 3.39, p = 0.035; Corrected Model: F(23,343) = 1.78, p = 0.016, R2 = 0.11).